Cross-reacting recombinant porcine FVIII inhibitors in patients with acquired haemophilia A.

Annette Elizabeth BowyerFiona ShepherdSean PlattonSusan GuySteve KitchenRhona Maclean

Published in: Haemophilia : the official journal of the World Federation of Hemophilia (2020)

Cross-reactivity between FVIII inhibitors and rpFVIII was observed in 49% of patients. The presence of inhibitors to rpFVIII may influence the treatment choice for patients with acquired haemophilia A.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
prognostic factors
cell free
smoking cessation